搜索





搜索





Recursion Pharmaceuticals Inc

RXRX

添加自选

3.200USD

+0.040+1.27%

收盘 09-11 16:00（美东）

1.70B总市值

亏损市盈率 TTM

盘后交易 18:44 (美东)3.200USD+0.010+0.31%

Recursion Pharmaceuticals Inc

3.200

+0.040+1.27%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

RXRX 利润表

您可以在这里找到Recursion Pharmaceuticals Inc的年度或季度收入报告，以深入了解Recursion Pharmaceuticals Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q2

营业总收入

-60.10%7.67M

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

营业收入

-60.10%7.67M

-56.11%6.47M

681.74%35.54M

-80.16%5.17M

33.34%19.22M

6.89%14.74M

-58.26%4.55M

147.62%26.08M

30.86%14.42M

13.68%13.79M

-20.36%10.89M

-19.96%10.53M

43.56%11.02M

127.53%12.13M

439.91%13.68M

419.34%13.16M

201.06%7.67M

108.16%5.33M

--2.53M

1270.43%2.55M

--2.56M

--186.00K

主营业务成本

-43.00%11.49M

-42.78%12.49M

11.58%14.28M

21.59%14.69M

119.17%20.16M

95.50%21.83M

29.48%12.79M

11.05%12.08M

-1.95%9.20M

-10.30%11.17M

-8.85%9.88M

-29.41%10.88M

-34.05%9.38M

59.61%12.45M

--10.84M

--15.41M

--14.23M

--7.80M

----

营业费用

-27.02%142.64M

-34.51%134.98M

-23.60%143.87M

42.54%177.38M

70.02%195.45M

87.15%206.11M

71.47%188.31M

13.04%124.44M

23.97%114.96M

36.31%110.13M

47.10%109.82M

45.36%110.08M

30.49%92.73M

31.78%80.80M

10.62%74.66M

54.76%75.73M

63.45%71.06M

85.54%61.31M

--67.49M

--48.94M

136.25%43.48M

--33.05M

--18.40M

研发费用

-39.43%77.91M

-41.99%75.20M

5.62%95.94M

71.72%121.06M

83.69%128.64M

102.05%129.63M

52.45%90.83M

5.84%70.50M

30.99%70.03M

37.90%64.16M

47.81%59.58M

63.41%66.61M

39.35%53.46M

43.75%46.52M

-12.36%40.31M

22.88%40.76M

29.83%38.36M

34.67%32.37M

--46.00M

--33.17M

123.10%29.55M

--24.03M

--13.24M

折旧摊销及损耗

-23.82%18.17M

1.77%19.67M

68.92%25.84M

120.12%21.04M

165.43%23.85M

161.23%19.33M

101.28%15.30M

25.79%9.56M

60.45%8.98M

97.23%7.40M

133.77%7.60M

154.27%7.60M

101.01%5.60M

35.16%3.75M

26.20%3.25M

16.03%2.99M

12.52%2.79M

87.82%2.78M

--2.58M

147.60%2.48M

--1.48M

--1.00M

营业利润

23.41%-134.97M

32.85%-128.50M

41.05%-108.33M

-75.08%-172.20M

-75.28%-176.23M

-98.64%-191.37M

-85.76%-183.77M

1.20%-98.35M

-23.04%-100.54M

-40.30%-96.34M

-62.23%-98.93M

-59.09%-99.55M

-28.91%-81.72M

-22.66%-68.67M

6.12%-60.98M

-34.85%-62.57M

-54.88%-63.39M

-83.64%-55.98M

---64.96M

---46.40M

-124.67%-40.93M

---30.48M

---18.22M

净非营业利息收入（费用）

利息收入

-2.52%5.31M

7.29%5.96M

35.45%6.26M

44.46%5.54M

66.66%5.44M

37.30%5.56M

2.17%4.62M

-22.95%3.83M

-34.11%3.27M

-13.13%4.05M

22.81%4.52M

171.52%4.98M

660.28%4.96M

5256.32%4.66M

--3.68M

3566.00%1.83M

2148.28%652.00K

443.75%87.00K

----

--50.00K

20.83%29.00K

--16.00K

--24.00K

利息费用

-35.63%309.00K

-31.10%350.00K

----

48.22%833.00K

21.83%480.00K

2440.00%508.00K

2226.92%605.00K

2148.00%562.00K

1415.38%394.00K

5.26%20.00K

100.00%26.00K

92.31%25.00K

85.71%26.00K

35.71%19.00K

--13.00K

-94.09%13.00K

-99.44%14.00K

-94.38%14.00K

----

--220.00K

487.09%2.50M

--249.00K

--426.00K

特殊收入（费用）

----

--0.00

-1208.33%-15.70M

----

0.00%-1.20M

--0.00

100.00%0.00

---1.20M

--0.00

100.00%0.00

---2.80M

----

--0.00

---827.00K

----

其他非经营性收入（费用）

-63.51%-1.03M

225.04%784.00K

-805.62%-6.03M

983.00%5.25M

-61.48%-633.00K

-491.88%-627.00K

132.55%854.00K

-137.57%-594.00K

-775.86%-392.00K

255.34%160.00K

-1365.92%-2.62M

413.31%1.58M

928.57%58.00K

-45.07%-103.00K

-717.24%-179.00K

1162.07%308.00K

---7.00K

---71.00K

--29.00K

---29.00K

----

---324.00K

税前利润

23.79%-131.01M

39.74%-122.11M

39.57%-108.10M

-69.58%-162.25M

-75.29%-171.90M

-119.90%-202.65M

-84.32%-178.90M

-2.86%-95.67M

-27.81%-98.06M

-41.06%-92.15M

-68.82%-97.06M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

所得税

---1.00K

-2813.92%-4.60M

185.71%20.00K

-98.20%3.00K

100.00%0.00

79.72%-158.00K

100.17%7.00K

--167.00K

---523.00K

---779.00K

---4.06M

----

除税后利润

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

持续经营利润

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

归属于母公司的净利润

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

归属于普通股东的净利润

23.79%-131.00M

41.97%-117.50M

39.56%-108.12M

-69.29%-162.25M

-76.23%-171.90M

-121.60%-202.49M

-92.38%-178.91M

-3.04%-95.84M

-27.13%-97.54M

-39.87%-91.37M

-61.75%-93.00M

-53.89%-93.02M

-17.03%-76.73M

-16.70%-65.33M

11.46%-57.49M

-27.45%-60.45M

-51.06%-65.56M

-82.24%-55.98M

---64.93M

---47.43M

-129.11%-43.40M

---30.72M

---18.94M

基本每股收益

40.26%-0.25

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

稀释每股收益

40.26%-0.25

55.84%-0.22

61.03%-0.21

-7.03%-0.36

-2.27%-0.41

-29.86%-0.50

-31.70%-0.53

22.46%-0.34

-3.17%-0.40

-13.56%-0.39

-30.45%-0.40

-25.51%-0.44

-2.53%-0.39

-3.95%-0.34

19.05%-0.31

-23.84%-0.35

-21.36%-0.38

-79.71%-0.33

---0.38

---0.28

-168.52%-0.31

---0.18

---0.12

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Recursion Pharmaceuticals Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 RXRX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Recursion Pharmaceuticals Inc 财年末的营收是多少？



Recursion Pharmaceuticals Inc 2025 财年营收为 74.68M，高于上一财年的58.84M。

Recursion Pharmaceuticals Inc 最近一个季度的营收是多少？



Recursion Pharmaceuticals Inc 最近一个季度的营收为 7.67M，同比增长 -60.10%。

Recursion Pharmaceuticals Inc 全年的净利润是多少？



Recursion Pharmaceuticals Inc 2025 财年净利润为 -644.76M。

Recursion Pharmaceuticals Inc 上一季度的净利润是多少？



Recursion Pharmaceuticals Inc 最近一个季度的净利润为 -131.00M。

Recursion Pharmaceuticals Inc 年度营业利润是多少？



Recursion Pharmaceuticals Inc 2025 财年的营业利润为 -648.13M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。